Organovo

$8.41
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.31 (-3.56%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Organovo and other stocks, options, and ETFs commission-free!

About ONVO

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.

CEO

Keith Murphy

Employees

Headquarters

San Diego, California

Founded

2012

Market Cap

62.53M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

129.83K

High Today

$8.90

Low Today

$8.31

Open Price

$8.90

Volume

135.80K

52 Week High

$23.92

52 Week Low

$5.80

ONVO Earnings

-$1.36

-$0.91

-$0.45

$0.00

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Estimated

— per share

Actual

Expected May 27, After Hours